共 63 条
[1]
Haylen BT(2010)An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction Int Urogynecol J 21 5-26
[2]
de Ridder D(2008)Prevalence of urinary incontinence in men, women, and children: current evidence-findings of the fourth international consultation on incontinence Urology 2010 265-270
[3]
Freeman RM(2006)Duloxetine versus placebo for the treatment of Korean women with stress predominant urinary incontinence Korean J Urol 47 527-535
[4]
Buckley BS(1995)Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloraloseanesthetized female cat J Pharmacol Exp Ther 274 1014-1024
[5]
Lapitan MC(2008)Duloxetine versus placebo for the treatment of women with stress predominant urinary incontinence in Taiwan: a double-blind, randomized, placebo-controlled trial BMC Urology 8 2-318
[6]
Mah SY(2004)Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial BJU Int 93 311-257
[7]
Lee KS(2004)Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence BJOG 111 249-519
[8]
Choo MS(2004)Pharmacological treatment of women awaiting surgery for stress urinary incontinence Obstet Gynecol 104 511-1263
[9]
Thor KB(2003)Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence J Urol 170 1259-48
[10]
Katofiasc MA(2002)Duloxetine versus placebo in the treatment of stress urinary incontinence Am J Obstet Gynecol 187 40-56